Skip to content

Survey of Optical Values of the Breast Using Radiation-Free Pressure-Free Optical Scanning

Early Screening of Breast Cancer Using Radiation-Free Pressure-Free Optical Scanning

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00671385
Enrollment
2000
Registered
2008-05-05
Start date
2008-04-30
Completion date
2011-04-30
Last updated
2011-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign Growth, Breast, Breast Cyst, Breast Lesions, Early-Stage Breast Cancer

Keywords

screening, compositional analysis, metabolism, breast, breast cyst, breast infection, breast inflammation, lipoma, benign growth, Women without a diagnosis for a region of interest in the breast

Brief summary

The purposes of this study is to establish normal optical values of breast tissue in the general population. This will allow for establishing normals for breast composition, and is expected to be useful in the classification of breast lesions into groups such as cysts, benign growths, inflammatory lesions, and possibly early breast cancer.

Interventions

None listed

Sponsors

Stanford University
CollaboratorOTHER
University of California
CollaboratorOTHER
Palo Alto Medical Foundation
CollaboratorOTHER
Spectros Corporation
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
21 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* You must be female * You must be 21 to 50 years old * You must not have or have had breast cancer. * You must not have or have had breast implants or breast surgery * You must not have had a breast biopsy or injury, or a breast infection, in 90 days.

Exclusion criteria

* Any one or more of the above conditions not met * Lack of informed consent

Design outcomes

Primary

MeasureTime frame
Optical normals for the breast for a variety of conditions3 years

Secondary

MeasureTime frame
Diagnostic compositional standards for (a) diagnosis of a condition such as cyst, benign growth, inflammation, and/or (b) referral for additional evaluation of a region of interest.1 year

Countries

United States

Contacts

Primary ContactLizzy van Thillo, AA
lizzy@spectros.com650-851-4040
Backup ContactCarrie Bomarito, RN
info@spectros.com650-851-4040

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026